APA (7th ed.) Citation

A. M. van Hulst, E. J. Verwaaijen, M. F. Fiocco, S. M. F. Pluijm, M. A. Grootenhuis, R. Pieters, . . . M. M. van den Heuvel-Eibrink. (2021). Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design. BMC.

Chicago Style (17th ed.) Citation

A. M. van Hulst, E. J. Verwaaijen, M. F. Fiocco, S. M. F. Pluijm, M. A. Grootenhuis, R. Pieters, E. L. T. van den Akker, and M. M. van den Heuvel-Eibrink. Study Protocol: DexaDays-2, Hydrocortisone for Treatment of Dexamethasone-induced Neurobehavioral Side Effects in Pediatric Leukemia Patients: A Double-blind Placebo Controlled Randomized Intervention Study with Cross-over Design. BMC, 2021.

MLA (9th ed.) Citation

A. M. van Hulst, et al. Study Protocol: DexaDays-2, Hydrocortisone for Treatment of Dexamethasone-induced Neurobehavioral Side Effects in Pediatric Leukemia Patients: A Double-blind Placebo Controlled Randomized Intervention Study with Cross-over Design. BMC, 2021.